The development of diastolic dysfunction in patients with chronic kidney disease may result from disorders of (Ca-P) metabolism, including hypocalcemia, decreased levels of calcitriol, and increased levels of serum phosphorus and parathyroid hormone (PTH). This evidence concerns the gene PTH and Hypocalcemia.